Be careful lor.... most penny stock are for trader who con people to buy and they sell.... They are not mearnt for long term... Stock price doesnot mean it will go up..in fact, it will stagnant and go down further.... LOL :-)
This stock is a matter of time. May be late or early. I do not know the time frame. Expect a big play. Company earnings this Q is exceptional good. Today’s drop is all T3/T4 issue. Next week result announcement.
Author: share4all Publish date: Tue, 25 Sep 2018, 12:02 AM
Close
BCMALL (0187) – BCM Alliance Berhad
BCM involved in the distribution of commercial laundry equipment (15 years) & medical devices (10 years) in Malaysia. Revenue contributed by business segment
Prospects: 1) Setting up of Speed Queen self-service launderette outlets 2) Continuous expansion of existing portfolio of products and brands 3) Expansion of healthcare products segment in year 2018 4) Broaden new customer base and continuous enhance relationship on existing customer base 5) Management expects medical device division to be keyengine for earnings growth in the future as they expect to see slowdown in laundry equipment business due to market saturation. 6) To expand its medical devices segment, BCM acquired 51.03% stake in Cypress Medic Sdn Bhd (healthcare company), with profit guarantee of RM600K during first year. 7) Aiming to transfer from ACE market to main board in next two years
Commercial laundry equipment (contributed 58% to FY17 revenue). Growth in this segment is driven by rising popularity and demand of self-service laundrettes, conversion of traditional laundry service to self-service launderettes and increasing demand from healthcare services and hospitality sectors. The successful penetration into the Borneo region has opened new markets for BCM.
BCM has plans to set up 11 new Speed Queen self-service launderettes and concept stores throughout Malaysia. As at end-1QFY18, the company has set-up four outlets in Selayang, Sri Kembangan and Johor Bahru. It is currently identifying suitable locations in Klang Valley and Johor for the setting up of the remaining 7 outlets.
Medical devices (42% to revenue) industries. For this segment, demand is driven by the increasing number of healthcare providers, clinics, diagnostic imaging centres, and private and government hospitals throughout Malaysia. In addition, the securing of new products/brands also served to enhance the growth avenues in this division. In Feb-18, it was appointed as the distributor for Siemens Healthineers’ cardiac angiography system and fluoroscopy system. Overall, demand in the medical devices segment will be driven by the increasing need of a growing and ageing population, the promotion of Malaysia as a medical tourism hub and its new healthcare products segment.
New kid on the block - Healthcare products. The acquisition of a 51.03% stake in Cypress Medic in Feb would expand its reach into the distribution of healthcare products and clinical services in the retail market/pharmacies, which is complementary to its current distribution of consumable medical devices. Cypress Medic’s core business is in the trading and distribution of surgical, implants and clinical devices such as blood pressure monitor, nebuliser, thermometer, body fat monitor and sphygmomanometer for the medical devices market in Malaysia.
FA: Both revenue and eps in the last two quarter obviously shows a lot of improvement, we are expecting further improve in the coming quarter result
TA: BCM next resistance level is RM0.23, If it can break through the resistance, we should expect it will spike up at least to RM0.275, return to the pricing of the first day listed in Bursa market
Uptrend intact after trading above 200d SMA. After a 14M downward consolidation, BCMALL finally broke out the LT downtrend line and gradually building higher highs supports to hit a 52-week high of RM0.25 (1 Oct) before profit taking pullback to end at RM0.215 last Friday. We believe taking a breather is not unusual when prices have st retched too far from its downtrend line near RM0.165, and upon the completion of the current consolidation, the stock’s uptrend may potentially resume. A st rong breakout above RM0.225 (mid Bollinger band) will pave a smoother path towards RM0.25 and our LT objective at all-time high of RM0.275 (24 Oct 2016). Key supports are RM0.195-0.20. Cut loss at RM0.19.
Revenue for medical devices delay,will bill in next quarter and 2019. Hold 38m project for Columbia Asia and kpj High admin expense That's why profit down due to delay in revenue and high admin expense. However,next quarter seem will be much improved after bill in current revenue
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
moneykj
6,141 posts
Posted by moneykj > 2018-08-16 13:51 | Report Abuse
But if Hbglobal close at 0.14 today, the rally could start as early as tomorrow.